Почетна › Кронова болест › Masachuset
Kliničke studije za Кронова болест u državi Masachuset
25 studija za Кронова болест traži učesnike na lokacijama u državi Masachuset.
Gradovi u državi Masachuset
Zvanični tekst studije (na engleskom)
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- Boston Children's Hospital, Boston
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 13 до 20 · Оба пола · Ажурирано 13. 11. 2026. · NCT04508088Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Boston
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Boston Childrens Hospital, Boston
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, New Bedford
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400022, Boston
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tufts Medical Center-Site Number: 8400126, Boston
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
Тражи се учесникФаза 3
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Boston Children's Hospital, Boston
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 7. 10. 2026. · NCT05509777Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 14 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT06655415Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Massachusetts General Hospital, Boston
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 10. 2026. · NCT07033208Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Lucida Clinical Trials /ID# 266548, New Bedford
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Тражи се учесникФаза 1/2
Узраст од 12 до 80 · Оба пола · Ажурирано 3. 8. 2026. · NCT04263831A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Boston Children's Hospital, Boston
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 5. 5. 2026. · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, LLC, New Bedford
- University of Massachusetts, Worcester, Worcester
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 4. 2026. · NCT06456593Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
Тражи се учесникОпсервациона студија
Узраст од 18 до 99 · Оба пола · Ажурирано 12. 3. 2026. · NCT06252493Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Massachusetts General Hospital, Boston
Тражи се учесникЗдраве особе су добродошле
Узраст 14 и старији · Оба пола · Ажурирано 30. 1. 2026. · NCT05332639A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Massachusetts General Hospital, Boston
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 12. 2025. · NCT07219537High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
Тражи се учесникОпсервациона студија
Узраст од 5 до 25 · Оба пола · Ажурирано 3. 3. 2025. · NCT04331639Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.